Pleurodesis Using Mistletoe Extract Delivered via a Spray Catheter during Semirigid Pleuroscopy for Managing Symptomatic Malignant Pleural Effusion
- Document Type
- Publications · Journal Article
- Registered DB
- SCIEScopus
- Journal Ranking
- JCR Q3Scopus Q1
- Journal
- RESPIRATION95(3) · pp.177 · 2018
- Citation
- Web of Science 8Scopus 9
- FWCI (Scopus)
- 0.57
- JCR IF
- JCR 2017 2.591
- ISSN
- 0025-7931
Authors
- Eom, Jung SeopFirst authorCorresponding authorBiomedical Research Institute, Pusan National University Hospital, Busan, South Korea
- Ahn, Hyo YeoungDepartment of Thoracic and Cardiovascular Surgery, Pusan National University School of Medicine, Busan, South Korea
- Mok, JeonghaDepartment of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- Lee, GeewonDepartment of Radiology, Pusan National University School of Medicine, Busan, South Korea
- Cho, Eun JungDepartment of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- Kim, Mi-HyunDepartment of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- Lee, KwanghaDepartment of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- Kim, Ki UkDepartment of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- Park, Hae KyungDepartment of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- Lee, Min KiDepartment of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
Abstract
Background: Talc poudrage during thoracoscopy is considered the standard procedure for patients with symptomatic malignant pleural effusion (MPE). Until now, no alternative technique other than talc poudrage for pleurodesis during medical thoracoscopy has been proposed. Liquid sclerosants, such as mistletoe extract, have been sprayed evenly into the pleural cavity during semirigid pleuroscopy for chemical pleurodesis. Objective: We conducted a retrospective study using the database of semirigid pleuroscopy to identify the usefulness of pleurodesis using a mistletoe extract delivered via a spray catheter during semirigid pleuroscopy for symptomatic MPE. Methods: All consecutive patients with symptomatic MPE who underwent semirigid pleuroscopy from October 2015 to September 2016 were registered. The responses were evaluated using chest X-ray or computed tomography 4 weeks after pleurodesis. Results: The study included 43 patients who underwent pleurodesis with mistletoe extract via a spray catheter during semirigid pleuroscopy. Complete and partial responses were seen in 21 (49%) and 19 (44%) patients, respectively. The median duration of chest tube placement after pleurodesis was 7 days (range 6-8 days) in the 40 patients with complete or partial responses. No cases of severe hemorrhage, empyema formation, respiratory failure, or procedure-related mortality were observed in the subjects at 4 weeks after semirigid pleuroscopy. Conclusion: Pleurodesis with mistletoe extract delivered via a spray catheter during semirigid pleuroscopy is a safe and effective procedure for managing symptomatic MPE. (C) 2017 S. Karger AG, Basel
Keywords
Malignant pleural effusionMistletoePleurodesisPleuroscopyTALC POUDRAGEMANAGEMENTTHORACOSCOPYSLURRY
Identifiers
- Scopus EID
- 2-s2.0-85033478062
- WoS UID
- 000427733000006



Login
Back to Publication list